Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in Base to Base Biotech Podcast
A podcast episode covering the world’s first commercialization of a federated learning-based AI drug discovery platform—developed by Elix and LINC using AI models trained on data from 16 pharmaceutical companies—was featured in Base to Base Biotech on August 8th.
▼ Base to Base Biotech (August 8th, 2025)
Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA